Here is a copy of a presentation that I used to teach a MBA Class at the Wharton School on Feb 14, 2017

1. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Sundeep Bhan
The Invisible Success Factors

2. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Agenda
1. Me and Prognos
2. The Practical - Why?
3. How we are building Prognos
4. Why the Culture Guide?
5. Amazing people
a. Find them, motivate them, incent them,
6. Q&A

3. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Mission: To improve health by tracking and predicting disease
the earliest
● Healthcare AI leader in clinical diagnostics
● Prognos Registry - 5Bn Records on 100m patients
across 35 disease areas
● Specialized in deep learning (500 algorithms)
collecting and harmonizing clinical diagnostic data
Our comprehensive solutions help:
● Life Sciences brands identify patients in need of
therapy the earliest
● Diagnostics companies improve performance and
outcomes
● Payers close gaps in care and improve and
measure quality
SnapshotPrognos is:
Financing
• Series B - $15M
• Series A - $7M
• Seed $750K
Dx Data Access
ClientsKey Stats
ARC, Esther Dyson
• 140+ Labs
• High Volume Labs
• Specialized Labs
2014 2015 2016*
Conditions 7 26 53
Pharma 9 15 30
Payers 0 0 3
Technology

4. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Prognos Business Overview
Quality Improvement and Risk
Management
CareAlerts
RiskAlerts
Strategic partnerships
Market Intelligence
800+ Brands
$2B Market
Patient Acquisition and
Physician Profiling
Trigger
Profiler
Tracker
Life Sciences
Prognos Registry (5B Records for 100m patients)
1000+ Payers
$3.4B Market
Payers
6,000
Labs
(Highly
Fragmented)
$2B Market
Diagnostics
Opal De-ID

5. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Customer Needs / Differentiation (no barriers to entry) / Bad
leadership / Execution / Bad business model /
The Practical

6. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Startup Growth Charts
Change is constant
From Paul Grahan - YCombinator

7. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Building Prognos
Vision/Mission
Culture/Values
Products/Markets/Business Model
the invisible

8. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
When we first start in 2010...
1. Started with the founders
2. It’s not perfect
3. Scaling?
4. Choices (not rules)
a. People, Investors, Clients, Partners,

9. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Prognos Mission
Why?
Why?
Improve health
How?
Track and Predict (Leverage clinical data, analytics and AI)
What?
Earliest prognosis
To improve health by tracking and predicting
disease the earliest

10. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Prognos Vision
Why?
Why?
so that humanity reaches its full potential
How?
Tracking and predicting and to help cure and prevent
What?
To eradicate disease
“To eradicate disease so that humanity
reaches its full potential”

11. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Dimensions of our
Culture at Prognos
1. We Live by our Values
2. Prognos World Order
3. Awesome Team with Amazing
People
4. Alignment and Autonomy
(context, not control,
Accountability, Empowerment,)
5. My Growth and Development

12. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.

13. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.

14. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Amazing People - Attract them
1. No recruiters
2. The network (Linkedin)
3. Mission based worked
4. Filters

15. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Scorecard for Hiring - Objective Criteria

16. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Fit with
values
Performance
Aligned
Unaligned
StrongWeak
Move &
Develop
Grow &
Promote
Manage
Out
Wrong
Hire,
Exit Fast
Prognos Performance / Values Matrix
Awesome team with amazing people

17. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
Amazing People - Motivate them

18. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
● Increase clinical diagnostic data to expand xxx
● Sign XXXX
● Life Sci - $XXM in bookings
● Payers - $XXM in bookings and $XXM in revenues
● Deliver sustainable value to xxxxxxxxxx
● XX AI Projects in to enhance our info assets and
create nextgen products
● XX% of xxx agreements with xxxxxx
Prognos 2017
Deliver value - to Payers, Life Sci, & Diagnostic2
Build - Long Term Value
Courageous &
Honest
Enthusiastic Focused
Go Above &
Beyond
Collaborative
Vision: To eradicate disease so
that humanity reaches its full
potential
Mission: To improve health by
tracking and predicting disease
the earliest
OUR VALUES
Curious
Drive - Data Growth1
3

19. PROGNOS - CONFIDENTIAL AND PROPRIETARY, NOT INTENDED FOR FURTHER DISTRIBUTION. All Rights Reserved.
GET LUCKY
“Fortune favors the prepared mind” -- Louis Pasteur
"The more I prepare, the luckier I get." - Arnold Palmer